A pilot study of outpatient management of febrile neutropenic children with cancer at low risk of bacteremia.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 8648546.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Febrile neutropenic children with cancer were eligible for outpatient management with intravenous ceftriaxone therapy if they displayed selected low-risk criteria. Nineteen children were enrolled. All patients had sterile blood cultures, and only one of them was hospitalized because of persistent fever. This pilot study suggests that selected children with febrile neutropenia might be successfully managed without hospitalization.
Medical subject headings
- Antineoplastic Combined Chemotherapy Protocols
- Bacteremia
- Ceftriaxone
- Cephalosporins
- Fever of Unknown Origin
- Neoplasms
- Neutropenia